Vascular Distribution of Glioblastoma Multiforme at Diagnosis
- 1 March 2013
- journal article
- research article
- Published by SAGE Publications in Interventional Neuroradiology
- Vol. 19 (1) , 127-131
Abstract
Treatment of high-grade gliomas with selective intra-arterial (IA) administration of chemotherapies has been proposed, and utilized as a therapeutic modality. This approach offers the conceptual benefit of providing maximal delivery of the agent to the tumor bed, while potentially reducing systemic exposure to the agent. This retrospective study was designed to determine the vascular distribution of glioblastoma multiforme (GBM) at the time of diagnosis in an effort to determine what proportion of patients would likely be candidates for this approach. The preoperative MRI scans of 50 patients with GBM were analyzed and compared to published normative data of intracranial vascular distribution. Vascular distribution was determined by analyzing post-gadolinium axial and coronal T1 images, axial T2 images, and axial T2 images with an additional 1 cm margin (T2 + 1 cm) added in all dimensions. T1 analysis demonstrated 60% of tumors in a single vascular distribution. T2 analysis of these tumors reduced that number to 34%. When the T2 + 1 cm margin was utilized, only 6% of tumors were in a single vascular distribution. 66% of tumors were limited to the anterior circulation on T1 imaging but only 34% on T2 + 1 cm imaging. 30% of tumors were also within the distribution of the anterior choroidal artery. These findings suggest that the use of selective IA administration of agents is necessarily limited to a fraction of presenting patients or will require administration via multiple cerebral arteries.Keywords
This publication has 21 references indexed in Scilit:
- Superselective Intra-Arterial Cerebral Infusion of Novel Agents After Blood–Brain Disruption for the Treatment of Recurrent Glioblastoma Multiforme: A Technical Case SeriesNeurosurgery Clinics of North America, 2012
- Convection-enhanced delivery of therapeutic agents into the brain2012
- Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant gliomaJournal of Neurosurgery, 2011
- Poor drug distribution as a possible explanation for the results of the PRECISE trialJournal of Neurosurgery, 2010
- Survival comparison between glioblastoma multiforme and other incurable cancersJournal of Clinical Neuroscience, 2010
- Enhanced chemotherapy delivery by intraarterial infusion and blood‐brain barrier disruption in malignant brain tumorsCancer, 2005
- Intracarotid delivery of oncolytic HSV vector G47Δ to metastatic breast cancer in the brainGene Therapy, 2005
- Intra-arterial delivery of p53-containing adenoviral vector into experimental brain tumorsCancer Gene Therapy, 2002
- Variability of the territories of the major cerebral arteriesJournal of Neurosurgery, 1992
- Intraarterial Cis -Platinum Chemotherapy for Patients with Primary and Metastatic Brain TumorsCancer Drug Delivery, 1983